Cosimo D. Altomare

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells.

Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells.

Journal: ChemMedChem

Published: June 10, 2026

Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12-month real-world study in refractory and ultra-refractory focal epilepsy.

Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12-month real-world study in refractory and ultra-refractory focal epilepsy.

Journal: Epilepsia open

Published: March 30, 2026

Targeting GPR18: Structural modelling, ligand discovery, and therapeutic potential in neuroinflammatory disorders.

Targeting GPR18: Structural modelling, ligand discovery, and therapeutic potential in neuroinflammatory disorders.

Journal: Biochemical pharmacology

Published: February 10, 2026

MINERVA: a public XAI-powered platform advancing multi-target discovery in Alzheimer's disease.

MINERVA: a public XAI-powered platform advancing multi-target discovery in Alzheimer's disease.

Journal: Journal of cheminformatics

Published: February 09, 2026

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Journal: Computers in biology and medicine

Published: October 23, 2025

Investigating Amphoteric 3,4'-Biscoumarin-Based ortho-[(Dialkylamino)methyl]phenols as Dual MAO and ChE Inhibitors.

Investigating Amphoteric 3,4'-Biscoumarin-Based ortho-[(Dialkylamino)methyl]phenols as Dual MAO and ChE Inhibitors.

Journal: International journal of molecular sciences

Published: August 01, 2025

Bombyx Mori Silk Fibroin as a Sustainable Organocatalyst for Diastereoselective Michael Additions.

Bombyx Mori Silk Fibroin as a Sustainable Organocatalyst for Diastereoselective Michael Additions.

Journal: ChemSusChem

Published: March 19, 2025

Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.

Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.

Journal: Methods and protocols

Published: February 22, 2025

Chemical Space Networks Enhance Toxicity Recognition via Graph Embedding.

Chemical Space Networks Enhance Toxicity Recognition via Graph Embedding.

Journal: Journal of chemical information and modeling

Published: February 06, 2025

CUPID: A free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicity.

CUPID: A free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicity.

Journal: European journal of medicinal chemistry

Published: January 28, 2025

Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort.

Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort.

Journal: Orphanet journal of rare diseases

Published: January 07, 2025

Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor.

Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 07, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026